Your browser doesn't support javascript.
loading
Tryptophan-Kynurenine Pathway Activation and Cognition in Virally Suppressed Women With HIV.
Shorer, Eran Frank; Dastgheyb, Raha M; French, Audrey L; Daubert, Elizabeth; Morack, Ralph; Yohannes, Tsion; Clish, Clary; Gustafson, Deborah; Sharma, Anjali; Rogando, Andre; Qi, Qibin; Burgess, Helen; Rubin, Leah H; Weber, Kathleen M.
  • Shorer EF; Department of Neurology, Johns Hopkins Hospital, Baltimore, MD.
  • Dastgheyb RM; Department of Neurology, Johns Hopkins Hospital, Baltimore, MD.
  • French AL; Department of Medicine, Stroger Hospital of Cook County, Chicago IL.
  • Daubert E; Hektoen Institute of Medicine, Chicago, IL.
  • Morack R; Hektoen Institute of Medicine, Chicago, IL.
  • Yohannes T; Hektoen Institute of Medicine, Chicago, IL.
  • Clish C; Metabolomics Platform, Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA.
  • Gustafson D; Department of Neurology, State University of New York Downstate Medical Center, Brooklyn, NY.
  • Sharma A; Department of Medicine, Albert Einstein College of Medicine, Bronx, NY.
  • Rogando A; Hektoen Institute of Medicine, Chicago, IL.
  • Qi Q; College of Science and Health, Charles R. Drew University of Medicine and Science, Los Angeles, CA.
  • Burgess H; Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY.
  • Rubin LH; Department of Psychiatry, University of Michigan, Ann Arbor, MI; and.
  • Weber KM; Department of Neurology, Johns Hopkins Hospital, Baltimore, MD.
J Acquir Immune Defic Syndr ; 96(5): 494-500, 2024 08 15.
Article en En | MEDLINE | ID: mdl-38985447
ABSTRACT

BACKGROUND:

Immune and cognitive dysfunction persists even in virally suppressed women with HIV (VS-WWH). Since inflammation and HIV proteins induce the enzyme indoleamine 2,3-dioxygenase (IDO), converting tryptophan (T) to kynurenine (K) while producing downstream neurotoxic metabolites, we investigated IDO activation (KT ratio) in relation to cognition in VS-WWH and demographically similar women without HIV (WWoH).

METHODS:

Ninety-nine VS-WWH on stable antiretroviral therapy and 102 WWoH (median age 52 vs 54 years; 73% vs 74% Black, respectively) from the New York and Chicago sites of the Women's Interagency HIV Study (WIHS) completed a neuropsychological test battery assessing motor function, processing speed, attention/working memory, verbal fluency, verbal learning and memory, and executive function and had plasma measured for tryptophan-kynurenine metabolites through liquid chromatography-tandem mass spectrometry and monocyte-derived [soluble cluster of differentiation-14 (sCD14), soluble cluster of differentiation-163 (sCD163), monocyte chemoattractant protein-1 (MCP-1)] plus general inflammatory markers [tumor necrosis factor alpha-2 receptor (TNF-R2), high-sensitivity C-reactive protein, high-sensitivity interleukin-6] through enzyme-linked immunosorbent assays between 2017 and 2020.

RESULTS:

VS-WWH had a higher KT ratio (P < 0.01) and higher sCD14 levels (P < 0.05) compared with WWoH. Higher sCD163 was associated with higher KT ratio (R = 0.29, P < 0.01) and worse fine motor function in VS-WWH; after adjusting for sCD163 and sCD14 in multivariable regressions, higher KT ratio remained significantly associated with impaired fine motor function in VS-WWH only (standardized ß = -0.29, P < 0.05). IDO activation was not associated with cognition in WWoH.

CONCLUSIONS:

IDO activation (KT) was associated with worse fine motor control in VS-WWH independent of measured systemic inflammation. Further studies investigating biological mechanisms linking IDO activation to fine motor function among VS-WWH are warranted.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Triptófano / Infecciones por VIH / Indolamina-Pirrol 2,3,-Dioxigenasa / Quinurenina Límite: Adult / Female / Humans / Middle aged Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Triptófano / Infecciones por VIH / Indolamina-Pirrol 2,3,-Dioxigenasa / Quinurenina Límite: Adult / Female / Humans / Middle aged Idioma: En Año: 2024 Tipo del documento: Article